Non-ASH Events
November 6 - 10, 2024 | Houston, Texas
Society for Immunotherapy of Cancer’s 39th Annual Meeting and Pre-Conference Programs (SITC 2024)
CAR-T cells vs T-cell engaging bispecifics in Hematological Malignancies
Join our session to explore the latest advancements in CAR-T cells and bispecific T-cell engagers for the treatment of hematological malignancies. Discover the unique advantages, challenges, and opportunities of these novel therapies in revolutionizing patient outcomes. Learn about the current innovation in cell therapy and drug design but also the specific adverse events of such constructs. Don't miss this opportunity to gain insights from leading experts in the field and to access the latest advances from selected SITC abstracts.
SITC 2024 is the largest conference focused solely on cancer immunotherapy, providing international leaders from academia, regulatory and government agencies, and industry representatives, with a multidisciplinary environment focused on improving outcomes for all cancer patients.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission